The 34 references in paper E. Bogdanova O., O. Galkina V., I. Zubina M., V. Dobronravov A., Евдокия Богданова Олеговна, Ольга Галкина Владимировна, Ирина Зубина Михайловна, Владимир Добронравов Александрович (2016) “Klotho, фактор роста фибробластов 23 и неорганический фосфат на ранних стадиях хронической болезни почек // Klotho, fibroblast growth factor 23 and inorganic phosphate in early stages of cronic kidney disease” / spz:neicon:nefr:y:2016:i:4:p:54-61

1
Berndt T, Kumar R. Novel mechanisms in the regulation of phosphorus homeostasis. Physiology 2009; 24: 17-25
(check this in PDF content)
2
Kestenbaum В, Sampson JN, Rudser KD et al. Serum phosphate levels and mortality risk among people with chronic kidney disease. J Am SocNephrol 2005; 16(2): 520-528
(check this in PDF content)
3
Craver L, Marco MP, Martinez I et al. Mineral metabolism parameters throughout chronic kidney disease stages 1-5-achievement of K/DOQI target ranges. Nephrol Dial Transplant 2007; 22(4): 1171-1176
(check this in PDF content)
4
Hruska KA, Mathew S, Lund R et al. Hyperphosphatemia of chronic kidney disease. Kidney Int 2008; 74(2): 148-157
(check this in PDF content)
5
Hu MC, Kuro-o M, Moe OW et al. Klotho and chronic kidney disease. Contrib Nephrol 2013; 180: 47-63
(check this in PDF content)
6
Добронравов ВА. Современный взгляд на патофизиологию вторичного гиперпаратиреоза: роль фактора роста фибробластов 23 и Klotho. Нефрология 2011; 15(4): 11-20 [Dobronravov VA. Sovremennyj vzgljad na patofiziologiju vtorichnogo giperparatireoza rol’ faktora rosta fibroblastov 23 i Klotho. Nefrologija 2011; 15(4): 11-20]
(check this in PDF content)
7
Asai O, Nakatani K, Tanaka T et al. Decreased renal alphaKlotho expression in early diabetic nephropathy in humans and mice and its possible role in urinary calcium excretion. Kidney Int 2012; 81: 539–547
(check this in PDF content)
8
Pavik I, Jaeger P, Ebner L et al. Secreted Klotho and FGF23 in chronic kidney disease Stage 1 to 5: a sequence suggested from a cross-sectional study. Nephrol Dial Transplant 2013; 28(2): 352-359
(check this in PDF content)
9
Sakan H, Nakatani K, Asai O et al. Reduced Renal α-Klotho Expression in CKD Patients and Its Effect on Renal Phosphate Handling and Vitamin D Metabolism. PLoS One 2014; 9(1): e86301. doi: 10.1371/journal.pone.0086301
(check this in PDF content)
10
Fliser D, Kollerits B, Never U et al. Fibroblast growth factor 23 (FGF-23) predicts progression of chronic kidney disease: the Mild to Moderate Kidney Disease (MMKD) Study. J Am Soc Nephrol 2007; 18 (9): 2600–2608
(check this in PDF content)
11
Haruna Y, Kashihara N, Satoh M et al. Amelioration of progressive renal injury by genetic manipulation of Klotho gene. Proc Natl Acad Sci USA 2007; 104: 2331–2336
(check this in PDF content)
12
Wang Y, Sun Z. Klotho gene delivery prevents the progression of spontaneous hypertension and renal damage. Hypertension 2009; 54: 810–817
(check this in PDF content)
13
Aizawa H, Saito Y, Nakamura T et al. Downregulation of the Klotho gene in the kidney under sustained circulatory stress in rats. Biochem Biophys Res Commun 1998; 249: 865–871
(check this in PDF content)
14
Isakova T, Xie H, Barchi-Chung A et al. Fibroblast growth factor 23 in patients undergoing peritoneal dialysis. Clin J Am Soc Nephrol 2011; 6: 2688–9520
(check this in PDF content)
15
Kuro-o М. Phosphate and Klotho. Kidney Int 2011; 79 (121): 20–23
(check this in PDF content)
16
Yilmaz MI, Sonmez A, Saglam M et al. FGF-23 and vascular dysfunction in patients with stage 3 and 4 chronic kidney disease. Kidney Int 2010; 78 (7): 679–685
(check this in PDF content)
17
Levey AS, Stevens LA, Schmid CH et al A new equation to estimate glomerular filtration rate. Ann Intern Med 2009. 150(9):604–612
(check this in PDF content)
18
Kuro-o M, Matsumura Y, Aizawa H et al. Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature
(check this in PDF content)
19
7; 6;390(6655):45-51 19. Irifuku T, Doi S, Sasaki K. Inhibition of H3K9 histone methyltransferase G9a attenuates renal fibrosis and retains klotho expression. Kidney Int 2015;doi: 10.1038/ki.2015.291
(check this in PDF content)
20
Sutariya B, Jhonsa D, Saraf MN. TGF-β: the connecting link between nephropathy and fibrosis. Immunopharmacol Immunotoxicol 2016; 38(1):39-49
(check this in PDF content)
21
Fang Y, Ginsberg C, Seifert M et al. CKD-Induced Wingless/ Integration1 Inhibitors and Phosphorus Cause the CKD–Mineral and Bone Disorder. JASN 2014; 25(8):1760-1773
(check this in PDF content)
22
Tsujikawa H, Kurotaki Х, Fujimori T et al. Klotho, a gene related to a syndrome resembling human premature aging, functions in a negative regulatory circuit of vitamin D endocrine system. Mol Endocrinol 2003; 17 (12): 2393-2403
(check this in PDF content)
23
Forster RE, Jurutka PW, Hsieh JC. Vitamin D receptor controls expression of the anti-aging klotho gene in mouse and human renal cells. Biochem Biophys Res Commun 2011; 28;414(3):557-562
(check this in PDF content)
24
Borst MH, Vervloet MG, Ter Wee PM, Navis G. Cross talk between the renin-angiotensin-aldosterone system and vitamin D-FGF-23-klotho in chronic kidney disease. J Am Soc Nephrol 2011;22(9):1603-1609
(check this in PDF content)
25
Spichtig D, Zhang H, Mohebbi N. Renal expression of FGF23 and peripheral resistance to elevated FGF23 in rodent models of polycystic kidney disease. Kidney Int 2014;85(6):1340-1350
(check this in PDF content)
26
Rhee Y et al. Parathyroid hormone receptor signaling in osteocytes increases the expression of fibroblast growth factor-23 in vitro and in vivo. Bone 2011; 49: 636–643
(check this in PDF content)
27
Lavi-Moshayoff V, Wasserman G, Meir T et al. PTH increases FGF23 gene expression and mediates the high-FGF23 levels of experimental kidney failure: a bone parathyroid feedback loop. Am J Physiol Renal Physiol 2010; 299:F882–F889
(check this in PDF content)
28
Lypez I, RodrHguez-Ortiz ME, AlmadMn Y et al. Direct and indirect effects of parathyroid hormone on circulating levels of fibroblast growth factor 23 in vivo. Kidney Int 2011; 80 (5): 475-482
(check this in PDF content)
29
Добронравов ВА, Богданова ЕО, Семенова НЮ и др. Почечная экспрессия белка αKlotho, фактор роста фибробластов 23 и паратиреоидный гормон при экспериментальном моделировании ранних стадий хронического повреждения почек. Нефрология 2014; 18(2):72-78 [Dobronravov VA, Bogdanova EO, Semenova NJu i dr. Pochechnaja ehkspressija belka aKlotho faktor rosta fibroblastov 23 i paratireoidnyj gormon pri ehksperimental’nom modelirovanii rannih stadij hronicheskogo povrezhdenija pochek. Nefrologija 2014; 18(2):72-78]
(check this in PDF content)
30
Potts JT. Parathyroid hormone: past and present. J Endocrinol 2005; 187 (3): 311-325
(check this in PDF content)
31
Silver J, Naveh-Many T. FGF-23 and secondary hyperparathyroidism in chronic kidney disease. Nature Reviews Nephrology 2013; 9: 641-649
(check this in PDF content)
32
Pellicelli M, Taheri M, St-Louis M. PTHrP(1-34)-mediated repression of the PHEX gene in osteoblastic cells involves the transcriptional repressor E4BP4. J Cell Physiol 2012; 227(6):2378-2387
(check this in PDF content)
33
Rowe PSN. The chicken or the egg: PHEX, FGF23 and SIBLINGs unscrambled. Cell Biochem Funct 2012; 30(5):355-375
(check this in PDF content)
34
David V, Martin A, Hedge AM. ASARM peptides: PHEXdependent and -independent regulation of serum phosphate. Am J Physiol Renal Physiol 2011;300(3):783-791 Работа выполнена при поддержке Российского фонда фундаментальных исследований (грант
(check this in PDF content)